Born 1953.
Professor of Clinical Cardiovascular Reseach at the Lund University, Sweden, since 2008.
Served in the ESH Board and more recently as the chair of the ISH-RAG Europe group.
Main interest is hypertension, type 2 diabetes and early life programming of adult cardiometabolic health.
Meet the trialist - CAMELLIA-TIMI 61 - Cardiovascular and Metabolic Effects of Lorcaserin in Overweight and Obese Patients-Thrombolysis in Myocardial Infarction 61